B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2

Background: The COVID-19 pandemic, caused by SARS-CoV-2, has highlighted the need for vaccines targeting both neutralizing antibodies (NAbs) and long-lasting cross-reactive T cells covering multiple viral proteins to provide broad and durable protection against emerging variants. Methods: To address...

Full description

Bibliographic Details
Main Authors: Beatriz Perdiguero, Enrique Álvarez, Laura Marcos-Villar, Laura Sin, María López-Bravo, José Ramón Valverde, Carlos Óscar S. Sorzano, Michela Falqui, Rocío Coloma, Mariano Esteban, Susana Guerra, Carmen Elena Gómez
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/12/11/1213